Yu S, Matsumori Y, Kim BK, Gryglas-Dworak A, et al. Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized, double-blind, placebo-controlled SUNRISE trial. Cephalalgia 2025;45:3331024251386095.
PMID: 41091746